Skip to main content

Breadcrumb

  1. Home

Cardiovascular

Valid for Measure Submission

New Atrial Fibrillation: Thyroid Function Test

  • This measure identifies patients with new-onset atrial fibrillation during the measurement year who have had a thyroid function test 6 weeks before or after the diagnosis of atrial fibrillation.

    CBE ID
    0600

Percutaneous Coronary Intervention (PCI): Comprehensive Documentation of Indications for PCI

  • Percentage of patients, aged 18 years and older, for whom percutaneous coronary intervention (PCI) is performed with comprehensive documentation for the procedure that includes, at a minimum, the following elements: priority (acute coronary syndrome, urgent, elective, emergency/salvage); presence and severity of angina symptoms; use of antianginal medical therapies within two weeks prior to the procedure, if any; presence, results, and timing of non-invasive stress test, fractional flow reserve (FFR), or intravascular ultrasound (IVUS), if performed; and significance of angiographic stenosi

    CBE ID
    2411

Post MI: ACE inhibitor or ARB therapy

  • This measure identifies patients with ST elevation MI (STEMI), or non-ST elevation MI (NSTEMI) plus a history of hypertension, heart failure and/or diabetes prior to the measurement year who are taking an ACEI or an ARB during the measurement year.

    CBE ID
    0594

Post-Discharge Appointment for Heart Failure Patients

  • Patients for whom a follow-up appointment for an office or home health visit for management of heart failure was scheduled within 7 days post-discharge and documented including location, date, and time.

    CBE ID
    2439

Primary PCI received within 90 minutes of hospital arrival

  • Percentage of acute myocardial infarction (AMI) patients with ST-segment elevation or LBBB on the ECG closest to arrival time receiving primary percutaneous coronary intervention (PCI) during the hospital stay with a time from hospital arrival to PCI of 90 minutes or less.

    CBE ID
    0163